People

Read his academic papers on PubMed, Google Scholar, and arXiv, dissertation on ProQuest, and popular writings on Vector. In his free time, he likes to carry out elaborate experiments in the kitchen, with his kids serving as cooking research participants; some recipes on Vox Over. His book project with Alex Proekt Why Life:
Towards new physics of life to understand biological molecules, development, and disease
offers a synthesis of physics and biology through the lens of evolutionary physics, a framework that seeks to explain the distinguishing principles of living things.

Danmeng obtained her BS in Medicinal Chemistry from China Pharmaceutical University, and her PhD in Chemistry from University of Florida, where she studied with Hendrik Luesch on total synthesis and mechanisms of marine natural products. She is currently studying chemical proteomics and engineering of novel macromolecular delivery agents.

Masahiro is a hematologist who received his M.D. and Ph.D. from the University of Tokyo, where his research focused on molecular biology of epigenetic regulation. His current research interests include defining the mechanisms of leukemogenic transcription factor control and identifying neomorphic gene products required for leukemia cell survival and targeted therapy. 

Shuyuan is a graduate student in the Weill Cornell Biochemistry, Structural Biology, Cell Biology, Developmental Biology and Molecular Biology graduate program. She received her B.S. in Natural Sciences from Zhejiang University in China, where she studied cancer immunotherapy. Currently, she is studying mechanisms of transcription factor complex assembly and dysfunction in acute myeloid leukemia.

Makiko received her MD and PhD degrees from the Shimane University in Japan, having studied developmental and germ cell biology. She is interested in de novo genetics and their contributions to childhood cancers and other developmental disorders, with a particular focus on developmental mutators.

Helen received her BA in Biology from Columbia University. She then received her PhD from the Massachusetts Institute of Technology, where she studied the mechanisms and consequences of resistance to epigenetic targeted therapy in lung cancer. Her current research interests include elucidating and targeting transposase-activated signaling pathways in childhood cancers.

Ning received her PhD in Chemistry from Rutgers University. Her graduate research focused on synthesis and mass spectrometry of amphiphilic macromolecules. She is interested in macromolecular drug delivery and quantitative proteomics.

Anna is a graduate student in the Weill Cornell Pharmacology Graduate Program. She received her B.S. in Neuroscience and Behavioral Biology from Emory University in Atlanta, where her research focused on the mechanisms of neurodegenerative diseases using cryo-EM. Currently, she is working on defining the molecular mechanisms of developmental mutators and their therapeutic targeting.

Sophia received her B.A in Chemistry and Chemical Biology from Cornell University where she studied the relationship between the olfactory cortex and learning in mice. She is currently interested in researching molecular mechanisms and drug delivery approaches in oncology.

Alicia received her B.S. in Biomedical Engineering from Union College, New York. She is interested in protein regulation by post-translational modifications and drug delivery systems for cancer treatment.

Laura is a hematologist who received her MD from the University of Leipzig. During her residency in Hematology/Oncology at the University Hospital Ulm and Charité Berlin, she used functional genomics to investigate drug resistance mechanisms in AML and multiple myeloma. Currently, she is interested in defining mechanisms of persistence of measurable residual disease (MRD) cells in AML using proteogenomic approaches and how the leukemic niche supports drug resistance in AML.

Hannah is a pediatric hematologist-oncologist at Memorial Sloan Kettering/NYP-Weill Cornell. She received her MD from the Icahn School of Medicine at Mount Sinai and completed a pediatric residency at NYP-Columbia Presbyterian. She is interested in therapeutic genome editing. 

Anna received her MD from Hannover Medical School in Germany. She is interested in developmental mutators and their contributions to child cancer development.

Gaby is an alumna of the University of Bologna, Italy, where she received her PhD in biochemistry and molecular biology. She is interested in translational research, team science, and humans.

Jinxin received his PhD in Analytical Chemistry from Stevens Institute of Technology, where he developed new ion mobility mass spectrometry methods for mixture analysis. He is interested in genome-scale and comprehensive mass spectrometry proteomics.